NIH-funded research R01 grant

Understanding how heart cells develop and maintain their identity

Official title: Mechanisms governing the differentiation and maintenance of atrial identity

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11063165 · Data updated 2026-11-12

This study is looking at how certain genes affect the development of heart cells, especially in babies, to understand why some newborns have heart defects and to find better ways to treat these issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$573,472
NIH project number5R01HL168790-03
Project IDNIH-11063165 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include newborns and children diagnosed with congenital heart defects, particularly those with atrial septal defects.

Less likely to help

Patients with congenital heart defects that are not related to atrial development or those who are adults may not benefit from this research.

What this research studies

This research investigates the genetic and molecular mechanisms that are crucial for the proper development of heart cells, particularly focusing on atrial cardiomyocytes. It aims to uncover how mutations in specific genes can lead to congenital heart defects, which are common in newborns and can result in serious complications like arrhythmias. By studying these mechanisms, the research seeks to provide insights into the causes of these defects and improve treatment strategies. The approach involves analyzing gene expression and the role of transcription factors in heart development.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for congenital heart defects and associated arrhythmias.

How similar studies have gone: Previous research has shown success in understanding genetic mechanisms related to congenital heart defects, making this approach promising.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Waxman, Joshua — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Waxman, Joshua

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.